跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,854 条关于
“Lutetium Lu 177 dotatate”
全部
2,854
临床试验
1,460
药物
919
机构
14
资讯
461
去年
Lutetium Lu 177 Dotatate Shows Promise in Metastatic Bronchopulmonary Neuroendocrine Tumors
10个月前
Lutetium Lu 177 Dotatate Demonstrates Significant Efficacy in Advanced Intracranial Meningioma Phase 2 Trial
3年前
Nanopharmaceutics Completes Enrollment in Phase 2 Neuroendocrine Tumor Study Combining Triapine with Lutetium Lu 177 Dotatate
3个月前
Delaware Court Clears Path for Curium's Lutetium Lu 177 Dotatate in GEP-NETs, Invalidating Novartis Patents
去年
Nanopharmaceutics Completes Phase II Enrollment for Triapine Combination Therapy in Neuroendocrine Tumors
11个月前
Phase 2 Trial Shows 70% Response Rate for Novel Combination Therapy in Advanced Neuroendocrine Tumors
前天
FDA Approves Curium's Bexlutry, First Generic Radioligand, Challenging Lutathera's GEP-NET Monopoly
去年
Cabozantinib Shows Promise in Advanced GI Neuroendocrine Tumors
4个月前
Curium Knocks Out Novartis Cancer Drug Patents in Generics Fight
2年前
FDA Approves First Bispecific T-Cell Engager for Solid Tumors and Expands Indications for Immunotherapies
第 1 页,共 47 页
上一页
下一页